These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32402505)

  • 1. Clinicopathological and prognostic value of NADPH oxidase 2 (NOX2) in primary osteosarcoma.
    Lin RJ; Huang Z; Wang SL; Chen H; Wei HX; Shen RK; Yang LY; Lin JH
    J Orthop Sci; 2021 May; 26(3):466-472. PubMed ID: 32402505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
    Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
    Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
    Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
    World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
    Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
    J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
    Liu Y; Sun X; Huo C; Sun C; Zhu J
    Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
    Zhu H; Cai H; Tang M; Tang J
    Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
    Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
    J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
    Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
    World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.
    Zhong G; Wang Y; Wei H; Chen M; Lin H; Huang Z; Huang J; Wang S; Lin J
    Int J Gen Med; 2021; 14():6477-6485. PubMed ID: 34675615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.